314 related articles for article (PubMed ID: 33641055)
1. Molecular Pathology of Well-Differentiated Pulmonary and Thymic Neuroendocrine Tumors: What Do Pathologists Need to Know?
Volante M; Mete O; Pelosi G; Roden AC; Speel EJM; Uccella S
Endocr Pathol; 2021 Mar; 32(1):154-168. PubMed ID: 33641055
[TBL] [Abstract][Full Text] [Related]
2. Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D.
Simbolo M; Mafficini A; Sikora KO; Fassan M; Barbi S; Corbo V; Mastracci L; Rusev B; Grillo F; Vicentini C; Ferrara R; Pilotto S; Davini F; Pelosi G; Lawlor RT; Chilosi M; Tortora G; Bria E; Fontanini G; Volante M; Scarpa A
J Pathol; 2017 Mar; 241(4):488-500. PubMed ID: 27873319
[TBL] [Abstract][Full Text] [Related]
3. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
Swarts DR; Ramaekers FC; Speel EJ
Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
[TBL] [Abstract][Full Text] [Related]
4. Molecular alterations of neuroendocrine tumours of the lung.
Rossi G; Bertero L; Marchiò C; Papotti M
Histopathology; 2018 Jan; 72(1):142-152. PubMed ID: 29239031
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence of the neuroendocrine phenotype in thymus neoplasms].
Ferolla P; Urbani M; Ascani S; Puma F; Ribacchi R; Battista Bolis G; Santeusanio F; Daddi G; Angeletti G; Avenia N
Chir Ital; 2002; 54(3):351-4. PubMed ID: 12192931
[TBL] [Abstract][Full Text] [Related]
6. SATB2 Is Expressed in a Subset of Pulmonary and Thymic Neuroendocrine Tumors.
Vrana JA; Boland JM; Terra SBSP; Xie H; Jenkins SM; Mansfield AS; Molina JR; Cassivi SD; Roden AC
Am J Clin Pathol; 2021 Oct; 156(5):853-865. PubMed ID: 33978159
[TBL] [Abstract][Full Text] [Related]
7. Comparative immunohistochemical analysis of pulmonary and thymic neuroendocrine carcinomas using PAX8 and TTF-1.
Weissferdt A; Tang X; Wistuba II; Moran CA
Mod Pathol; 2013 Dec; 26(12):1554-60. PubMed ID: 23787439
[TBL] [Abstract][Full Text] [Related]
8. Comparative genomic hybridization analysis of thymic neuroendocrine tumors.
Pan CC; Jong YJ; Chen YJ
Mod Pathol; 2005 Mar; 18(3):358-64. PubMed ID: 15272285
[TBL] [Abstract][Full Text] [Related]
9. Thymic atypical carcinoid tumors with elevated mitotic counts in a patient with multiple endocrine neoplasia: A case report.
Hiro S; Teranishi S; Sawazumi T; Nagaoka S; Sugimoto C; Nagayama H; Segawa W; Kajita Y; Maeda C; Kubo S; Seki K; Tashiro K; Kobayashi N; Yamamoto M; Kudo M; Kaneko T
Thorac Cancer; 2023 May; 14(14):1311-1315. PubMed ID: 36941083
[TBL] [Abstract][Full Text] [Related]
10. [Neuroendocrine neoplasms of the mediastinum].
Brcic L; Heidinger M; Popper H
Pathologe; 2016 Sep; 37(5):434-40. PubMed ID: 27507161
[TBL] [Abstract][Full Text] [Related]
11. Recent advances and conceptual changes in the classification of neuroendocrine tumors of the thymus.
Bohnenberger H; Ströbel P
Virchows Arch; 2021 Jan; 478(1):129-135. PubMed ID: 33555458
[TBL] [Abstract][Full Text] [Related]
12. What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms?
Pelosi G; Fabbri A; Cossa M; Sonzogni A; Valeri B; Righi L; Papotti M
Semin Diagn Pathol; 2015 Nov; 32(6):469-79. PubMed ID: 26561395
[TBL] [Abstract][Full Text] [Related]
13. Two cases of lung neuroendocrine carcinoma with carcinoid morphology.
Inafuku K; Yokose T; Ito H; Eriguchi D; Samejima J; Nagashima T; Nakayama H; Suzuki M; Yamada K; Masuda M
Diagn Pathol; 2019 Sep; 14(1):104. PubMed ID: 31511024
[TBL] [Abstract][Full Text] [Related]
14. Lung carcinoid tumors with Diffuse Idiopathic Pulmonary NeuroEndocrine Cell Hyperplasia (DIPNECH) exhibit pejorative pathological features.
Prieto M; Chassagnon G; Lupo A; Charpentier MC; Cabanne E; Groussin L; Wislez M; Alifano M; Fournel L
Lung Cancer; 2021 Jun; 156():117-121. PubMed ID: 33940544
[TBL] [Abstract][Full Text] [Related]
15. Morphologic and molecular classification of lung neuroendocrine neoplasms.
Metovic J; Barella M; Bianchi F; Hofman P; Hofman V; Remmelink M; Kern I; Carvalho L; Pattini L; Sonzogni A; Veronesi G; Harari S; Forest F; Papotti M; Pelosi G
Virchows Arch; 2021 Jan; 478(1):5-19. PubMed ID: 33474631
[TBL] [Abstract][Full Text] [Related]
16. Lung Neuroendocrine Tumors: How Does Molecular Profiling Help?
Sun TY; Hendifar A; Padda SK
Curr Oncol Rep; 2022 Jul; 24(7):819-824. PubMed ID: 35305210
[TBL] [Abstract][Full Text] [Related]
17. Long Non-coding RNAs in Pulmonary Neuroendocrine Neoplasms.
Narayanan D; Mandal R; Hardin H; Chanana V; Schwalbe M; Rosenbaum J; Buehler D; Lloyd RV
Endocr Pathol; 2020 Sep; 31(3):254-263. PubMed ID: 32388776
[TBL] [Abstract][Full Text] [Related]
18. Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways.
Wang S; Gu Z; Zhu L; Han Y; Yu H; Fang W; Han B
Chin Med J (Engl); 2023 Nov; 136(22):2712-2721. PubMed ID: 37749819
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary neuroendocrine carcinomas. A review of 234 cases and a statistical analysis of 50 cases treated at one institution using a simple clinicopathologic classification.
Huang Q; Muzitansky A; Mark EJ
Arch Pathol Lab Med; 2002 May; 126(5):545-53. PubMed ID: 11958659
[TBL] [Abstract][Full Text] [Related]
20. Lung and Thymic Carcinoids.
Hann CL; Forde PM
Endocrinol Metab Clin North Am; 2018 Sep; 47(3):699-709. PubMed ID: 30098725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]